Clinical Trials for Relapsing Multiple Sclerosis

Find clinical trials for relapsing multiple sclerosis. Discover research opportunities and treatment options in your area.

15 Active Trials Found

Showing 15 trials on this page

Page 1 of 1

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT05147220

This clinical trial is investigating the effectiveness and safety of a new medication called remibrutinib compared to an existing treatment, teriflunomide, for people with relapsing multiple sclero...

Recruiting

Phase: PHASE3 Type: interventional Locations: Tampa, Florida, United States, Bronx, New York, United States +323 more

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT05156281

This clinical trial is studying the effectiveness and safety of a new treatment called remibrutinib compared to an existing drug, teriflunomide, in people with relapsing multiple sclerosis (RMS). R...

Recruiting

Phase: PHASE3 Type: interventional Locations: Milwaukee, Wisconsin, United States, Gainesville, Florida, United States +320 more

An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis

NCT ID: NCT06617793

This clinical trial is looking at a new treatment called YTB323 for people with relapsing multiple sclerosis (RMS) who have not responded well to their current medications. The study will include a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bern, , Switzerland, Darlinghurst, New South Wales, Australia +6 more

An Efficacy and Safety Study With Integrated Pharmacokinetics (PK) and Pharmacodynamic (PD) Assessment to Compare the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT06847724

This clinical trial is studying a new medication called CYB704, which is similar to an existing treatment for relapsing multiple sclerosis (MS) called Ocrevus. The main goal is to find out if CYB70...

Recruiting

Phase: PHASE3 Type: interventional Locations: Maitland, Florida, United States, Ormond Beach, Florida, United States

A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

NCT ID: NCT06143514

This clinical trial is studying how a medication called BRIUMVI™ (also known as Ublituximab) affects breast milk in women who are breastfeeding and have relapsing multiple sclerosis (RMS). The main...

Recruiting

Type: observational Locations: Wilmington, North Carolina, United States

Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod

NCT ID: NCT06529406

This clinical trial is looking at the safety and effectiveness of a medication called ozanimod for patients with relapsing forms of multiple sclerosis (MS) who have been stable for some time after ...

Recruiting

Phase: PHASE4 Type: interventional Locations: Cleveland, Ohio, United States, Aurora, Colorado, United States +1 more

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

NCT ID: NCT05877963

This clinical trial is studying a modified treatment approach using a drug called ublituximab for people with relapsing multiple sclerosis (RMS). The main goal is to see how effective this new regi...

Recruiting

Phase: PHASE3 Type: interventional Locations: Milwaukee, Wisconsin, United States, Raleigh, North Carolina, United States +32 more

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT06433752

This clinical trial is studying the real-world experience of people with Relapsing Multiple Sclerosis (RMS) who are treated with BRIUMVI® (ublituximab-xiiy). The goal is to understand how safe and ...

Recruiting

Type: observational Locations: Milwaukee, Wisconsin, United States, Urbana, Illinois, United States +55 more

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

NCT ID: NCT06846281

This clinical trial is studying a new treatment called remibrutinib for people living with relapsing multiple sclerosis (RMS) who are currently being treated with ocrelizumab. The main goal is to f...

Not yet recruiting

Phase: PHASE3 Type: interventional

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

NCT ID: NCT06372145

This clinical trial is investigating the long-term safety and tolerability of a medication called tolebrutinib for adults with different types of Multiple Sclerosis (MS), including relapsing forms ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Seoul, Seoul Teukbyeolsi, Korea, Republic Of, Santiago, Reg Metropolitana De Santiago, Chile +348 more

Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study

NCT ID: NCT05809986

This clinical trial, named "Ofatumumab in Portuguese Multiple Sclerosis Patients," is exploring how effective the medication Ofatumumab is for people with relapsing multiple sclerosis (RMS) based o...

Recruiting

Type: observational Locations: Amadora, , Portugal, Setubal, , Portugal +7 more

Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years

NCT ID: NCT05776888

This clinical trial is studying how early or late treatment with Ofatumumab (also known as Kesimpta®) affects patients with relapsing multiple sclerosis (RMS) over two years. Researchers want to se...

Recruiting

Type: observational Locations: Wels, , Austria, Vienna, , Austria +1 more

Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

NCT ID: NCT04047628

The BEAT-MS trial is studying two different treatment options for people with severe relapsing multiple sclerosis (MS) who haven't responded well to other therapies. The two treatments being compar...

Recruiting

Phase: PHASE3 Type: interventional Locations: Rochester, Minnesota, United States, Durham, North Carolina, United States +21 more

Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT04121065

This clinical trial is studying the role of specific genetic variations (known as ADA SNPs) in people with relapsing multiple sclerosis (RMS). RMS is a type of multiple sclerosis where patients exp...

Recruiting

Type: observational Locations: Pozzilli, Isernia, Italy

9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis

NCT ID: NCT04510220

This clinical trial is studying the effects of a medication called Ofatumumab in patients with relapsing forms of multiple sclerosis (MS). Specifically, the trial aims to understand how Ofatumumab ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Boston, Massachusetts, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions